The latest medical news on COPD

Papa, an at-home companionship and support platform, has partnered with Highmark Wholecare, a managed care organization, to address the social need...

Infection with rhinovirus, a virus that causes the common cold, combined with long-term exposure to cigarette smoke — two risk factors associated w...

Pulmonary rehabilitation programs can ease shortness of breath, and improve exercise capacity and quality of life in people with chronic obstructiv...

High levels of the progenitor marker LGR6 in lung samples of chronic obstructive pulmonary disease (COPD) patients may lock the lungs in a pro-rege...

ENA Respiratory is developing its first-in-class, broad-spectrum antiviral nasal spray — known as INNA-051 — for populations at risk of developing ...

Respira Labs has raised $2.8 million to help develop a wearable device that uses sound to evaluate lung function in people with respiratory conditi...

The U.S. Food and Drug Administration (FDA) has given final approval to Zydus Pharmaceuticals to start marketing roflumilast tablets at a dose of 5...

The U.S. Food and Drug Administration (FDA) has approved Lupin Limited’s generic form of Brovana (arformoterol tartrate) for treating bronchoconstr...

A Phase 2 trial designed to test a self-administered inhaled formulation of nitric oxide (NO) for adults with chronic obstructive pulmonary disease...

Abnormally high levels of iron inside airway immune cells are associated with more frequent lung infection-related exacerbations in people with chr...

A team of researchers have created a comprehensive blueprint of cells that are in the lungs of chronic obstructive pulmonary disease (COPD) patient...

Animal and human studies highlight the potential of nomacopan, an investigational inhaled medicine to alleviate severe exacerbations caused by infl...